Not available
Quote | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
Last: | $182.50 |
---|---|
Change Percent: | 1.7% |
Open: | $181.04 |
Close: | $182.50 |
High: | $182.67 |
Low: | $180.13 |
Volume: | 86,925,205 |
Last Trade Date Time: | 07/20/2021 04:42:03 am |
News | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...
2023-12-03 12:00:30 ET More on SPDR S&P Biotech ETF Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Biopharma Bounce-Back: From Policy Pains To Profitable Plains Biotechs rally with gene editing stocks among nota...
Message Board Posts | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
Subject | By | Source | When |
---|---|---|---|
znewcar1: ALXN 29% v22,3M c156.31 f218M Buy out | znewcar1 | investorshangout | 12/14/2020 10:15:38 PM |
JUST IN: $ALXN 2 Top Pharma Stocks to | whytestocks | investorshub | 10/24/2020 12:00:28 PM |
JUST IN: $ALXN Labor Day Special: 3 Deep-Discount | whytestocks | investorshub | 09/07/2020 12:00:23 PM |
ALXN SEC Admin. Proceeding: Cease and Desist Order: | Renee | investorshub | 07/02/2020 1:40:22 PM |
This Pharma is in due diligence with another | Inthe203 | investorshub | 01/25/2020 10:22:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...